Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.

FDA recall notice · announced August 30, 2023 · Tmc Acquisitions Llc Dba Tailor Made Compounding

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.

Reason for recall

Lack of Assurance of Sterility

Notes

Distribution: Nationwide within the USA
Lot/code information: Lot#: 07262326A1, BUD: 10/24/2023
Quantity: 9 vials
Status: Terminated
Products in this recall event:
- NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding. (D-1106-2023)
- Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding. (D-1105-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.